WO2008009924A3 - Indoles useful in the treatment of inflammation - Google Patents
Indoles useful in the treatment of inflammation Download PDFInfo
- Publication number
- WO2008009924A3 WO2008009924A3 PCT/GB2007/002704 GB2007002704W WO2008009924A3 WO 2008009924 A3 WO2008009924 A3 WO 2008009924A3 GB 2007002704 W GB2007002704 W GB 2007002704W WO 2008009924 A3 WO2008009924 A3 WO 2008009924A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- inflammation
- useful
- indoles useful
- indoles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
There is provided compounds of formula (I): wherein X1, R1, R2, R3, R4, R5, T and Y have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83145006P | 2006-07-18 | 2006-07-18 | |
| US60/831,450 | 2006-07-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2008009924A2 WO2008009924A2 (en) | 2008-01-24 |
| WO2008009924A3 true WO2008009924A3 (en) | 2008-03-27 |
Family
ID=38699134
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/GB2007/002704 Ceased WO2008009924A2 (en) | 2006-07-18 | 2007-07-18 | Indoles useful in the treatment of inflammation |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2008009924A2 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY32138A (en) | 2008-09-25 | 2010-04-30 | Boehringer Ingelheim Int | SUBSTITUTED AMIDES 2- (2,6-DICLORO-PHENYLAMINE) -6-FLUORO-1-METHYL-1H-BENCIMIDAZOL-5-CARBOXYL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS |
| UY32470A (en) * | 2009-03-05 | 2010-10-29 | Boehringer Ingelheim Int | DERIVATIVES OF 2- {2-CHLORINE-5 - [(REPLACED) METHYL] PHENYLAMINE} -1-METHYL] PHENYLAMINE} -1-METHYLBENCIMIDAZOL-5-CARBOXAMIDES-N- (SUBSTITUTED) AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS, COMPOSITIONS AND APPLIANCE |
| WO2010149685A1 (en) | 2009-06-24 | 2010-12-29 | Boehringer Ingelheim International Gmbh | New compounds, pharmaceutical composition and methods relating thereto |
| EA201200046A1 (en) | 2009-06-24 | 2012-08-30 | Бёрингер Ингельхайм Интернациональ Гмбх | NEW COMPOUNDS, PHARMACEUTICAL COMPOSITION AND RELATED METHODS |
| US8586604B2 (en) | 2010-08-20 | 2013-11-19 | Boehringer Ingelheim International Gmbh | Inhibitors of the microsomal prostaglandin E2 synthase-1 |
| US8759537B2 (en) * | 2010-08-20 | 2014-06-24 | Boehringer Ingelheim International Gmbh | 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents |
| US8486968B2 (en) | 2010-12-10 | 2013-07-16 | Boehringer Ingelheim International Gmbh | Compounds |
| US8674113B2 (en) | 2010-12-10 | 2014-03-18 | Boehringer Ingelheim International Gmbh | Compounds |
| US8466186B2 (en) | 2010-12-10 | 2013-06-18 | Boehringer Ingelheim International Gmbh | Compounds |
| WO2016109559A2 (en) | 2014-12-29 | 2016-07-07 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Small molecule inhibitors of lactate dehydrogenase and methods of use thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999043672A1 (en) * | 1998-02-25 | 1999-09-02 | Genetics Institute, Inc. | Inhibitors of phospholipase a2 |
| US6630496B1 (en) * | 1996-08-26 | 2003-10-07 | Genetics Institute Llc | Inhibitors of phospholipase enzymes |
| WO2005123673A1 (en) * | 2004-06-18 | 2005-12-29 | Biolipox Ab | Indoles useful in the treatment of inflammation |
| WO2006077364A1 (en) * | 2005-01-19 | 2006-07-27 | Biolipox Ab | Indoles useful in the treatment of inflammation |
| WO2006077367A1 (en) * | 2005-01-19 | 2006-07-27 | Biolipox Ab | Indoles useful in the treatment of inflamation |
-
2007
- 2007-07-18 WO PCT/GB2007/002704 patent/WO2008009924A2/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6630496B1 (en) * | 1996-08-26 | 2003-10-07 | Genetics Institute Llc | Inhibitors of phospholipase enzymes |
| WO1999043672A1 (en) * | 1998-02-25 | 1999-09-02 | Genetics Institute, Inc. | Inhibitors of phospholipase a2 |
| WO2005123673A1 (en) * | 2004-06-18 | 2005-12-29 | Biolipox Ab | Indoles useful in the treatment of inflammation |
| WO2006077364A1 (en) * | 2005-01-19 | 2006-07-27 | Biolipox Ab | Indoles useful in the treatment of inflammation |
| WO2006077367A1 (en) * | 2005-01-19 | 2006-07-27 | Biolipox Ab | Indoles useful in the treatment of inflamation |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008009924A2 (en) | 2008-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200637819A (en) | Indoles useful in the treatment of inflammation | |
| TW200637820A (en) | Indoles useful in the treatment of inflammation | |
| WO2008009924A3 (en) | Indoles useful in the treatment of inflammation | |
| TW200637818A (en) | Indoles useful in the treatment of inflammation | |
| WO2008129288A3 (en) | Disulfonamides useful in the treatment of inflammation | |
| MX2010002521A (en) | Bis-aromatic compounds useful in the treatment of inflammation. | |
| NO20080675L (en) | P38-Map kinase inhibitors and methods for their use | |
| GEP20115161B (en) | Heterocyclic amide derivatives useful as microbiocides | |
| WO2009138758A3 (en) | Bis-aryl compounds for use as medicaments | |
| WO2008057856A3 (en) | Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof | |
| WO2007117465A3 (en) | Indazole compounds | |
| MY146111A (en) | Acylaminopyrazoles as fgfr inhibitors | |
| WO2007105058A8 (en) | Pyrazole compounds | |
| WO2006023515A3 (en) | Novel thiazole inhibitors of fructose 1,6-bisphosphatase | |
| WO2009127822A3 (en) | Bis-aryl compounds for use as medicaments | |
| WO2007084728A3 (en) | 2-imino-benzimidazoles | |
| WO2007103839A3 (en) | Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors | |
| WO2008073452A8 (en) | Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors | |
| NO20081888L (en) | Triazole Compounds as Lipoxygenase Inhibitors | |
| WO2005005415A8 (en) | Indoles useful in the treatment of inflammation | |
| IL179607A0 (en) | Indoles useful in the treatment of inflammation | |
| NO20081804L (en) | Pyrazole compounds suitable for the treatment of inflammation | |
| IL179728A0 (en) | Indoles useful in the treatment of inflammation | |
| EA201200891A1 (en) | DERIVATIVES 3,4,4A, 10D-TETRAGIDRO-1H-TIOPIRANO [4,3-C] IZOHINOLINA | |
| WO2007099171A3 (en) | Bicyclo-pyrazoles active as kinase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07766273 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| NENP | Non-entry into the national phase |
Ref country code: RU |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 07766273 Country of ref document: EP Kind code of ref document: A2 |